PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2013Circulation Journal21 citationsOpen Access

Amiodarone-Induced Thyrotoxicosis Late After Amiodarone Withdrawal

AYAtsuhiko YagishitaHHHitoshi HachiyaMKMihoko Kawabata

Key Result

Late amiodarone-induced thyrotoxicosis occurred in 7% of patients after amiodarone withdrawal and was significantly associated with prior amiodarone-induced hypothyroidism (100% vs. 24%, P=0.002) and longer therapy duration.

Study Design

Type

Cohort (n=71)

Multicenter

No

Structured PICO

What is the incidence and what are the clinical characteristics of amiodarone-induced thyrotoxicosis occurring late after amiodarone withdrawal?

P
Population
71 patients (mean age 65 years, 27% female) who discontinued amiodarone after at least 1 month of therapy, followed retrospectively for a mean of 37 months to determine the incidence of late amiodarone-induced thyrotoxicosis.
E
Exposure
Amiodarone withdrawal after at least 1 month of therapy
C
Comparator
Patients who did not develop late amiodarone-induced thyrotoxicosis (non-AIT group)
O
Outcome
Incidence and clinical characteristics of amiodarone-induced thyrotoxicosis (AIT) occurring late after amiodarone withdrawalsafety

Amiodarone-induced thyrotoxicosis can develop months after drug withdrawal, particularly in patients with a history of amiodarone-induced hypothyroidism and long treatment duration, highlighting the need for continued thyroid monitoring.

Limitations

  • Retrospective study design with a small sample size.
  • Thyroid function was not fully evaluated at regular intervals in some patients, which may have led to an underestimation of asymptomatic late AIT incidence.
  • Retrospective design with a small sample size
  • Thyroid function was not fully evaluated at regular intervals in some patients, potentially leading to underestimation of asymptomatic late AIT

Abstract

BACKGROUND: Amiodarone-induced thyrotoxicosis (AIT) may develop long after amiodarone withdrawal. This study sought to determine the incidence and clinical characteristics of AIT after amiodarone withdrawal. METHODS AND RESULTS: The incidence and clinical characteristics of AIT were examined retrospectively in 71 patients (51 males, mean age 65±13 years) whose amiodarone therapy had been discontinued after at least 1 month of administration. Five (7%) patients developed AIT late after amiodarone withdrawal (11±3 months): 2 patients exhibited exacerbation of heart failure by atrial fibrillation, 2 developed dyspnea on exertion, and 1 patient was asymptomatic. The patients who developed AIT had a high incidence of amiodarone-induced hypothyroidism during amiodarone therapy (100 vs. 24%, P=0.002), had received amiodarone therapy for longer (76±86 months vs. 16±22 months, P<0.001), with a larger cumulative dose (271.1±268.5 g vs. 63.4±86.5 g, P<0.001) compared with those who did not. In all 5 patients, AIT resolved spontaneously within 5 months without the use of steroids. CONCLUSIONS: Occurrence of amiodarone-induced hypothyroidism during amiodarone therapy and long duration of therapy may be cautionary markers of late AIT.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yagishita et al. (2013) conducted a cohort in Amiodarone-induced thyrotoxicosis (n=71). Amiodarone therapy and withdrawal vs. Patients without late AIT was evaluated on Incidence of late amiodarone-induced thyrotoxicosis (AIT) after amiodarone withdrawal. Late amiodarone-induced thyrotoxicosis occurred in 7% of patients after amiodarone withdrawal and was significantly associated with prior amiodarone-induced hypothyroidism (100% vs. 24%, P=0.002) and longer therapy duration.

synapsesocial.com/papers/6a771c0b4fe2e6ffd8ec6b2ahttps://doi.org/10.1253/circj.cj-13-0220
Ask AI
Helpful
Bookmark
Share
View Full Paper